These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7690320)

  • 1. Management of the patient with left ventricular hypertrophy.
    de Divitiis O; Celentano A; De Simone G; Di Somma S; Galderisi M; Liguori V; de Divitiis M; Petitto M
    Eur Heart J; 1993 Jul; 14 Suppl D():22-32. PubMed ID: 7690320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.
    Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A
    Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case 3: A patient with systemic hypertension and left ventricular hypertrophy.
    Kloner RA; Friedewald VE
    Am J Cardiol; 2000 Feb; 85(4):522. PubMed ID: 10728968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and sudden cardiac death.
    Messerli FH
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):181S-188S. PubMed ID: 10619570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
    Agabiti-Rosei E
    Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of antihypertensive therapy: cardiac and extracardiac considerations.
    Messerli FH; Soria F
    Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy: impact of calcium channel blocker therapy.
    Messerli FH
    Am J Med; 1991 May; 90(5A):27S-31S. PubMed ID: 2039017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathology of left ventricular hypertrophy].
    Waeber B; Weber R; Brunner HR
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():9-14. PubMed ID: 7646313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances in the treatment of left ventricular hypertrophy.
    Natsume T
    Eur Heart J; 1993 Jul; 14 Suppl D():33-7. PubMed ID: 8370375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention, diagnosis, and treatment of hypertensive heart disease.
    Georgiopoulou VV; Kalogeropoulos AP; Raggi P; Butler J
    Cardiol Clin; 2010 Nov; 28(4):675-91. PubMed ID: 20937450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left ventricular hypertrophy with antihypertensive treatment].
    Galinier M; Bounhoure JP
    Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.